Alcon AG | ALC - Selling And Administration Expenses

Stock Price
61.16
Daily Change
0.32 0.53%
Monthly
-1.20%
Yearly
-22.46%
Q1 Forecast
59.31

Alcon AG reported $901M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 4.61B 4.46B Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Sonova Holding CHF 880.2M 300K Jun/2025
UCB EUR 1.29B 221M Dec/2024